Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 21 clinical trials
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

09/26/2018) Perivascular epithelioid cell tumor (PEComa) Apocrine tumors/extramammary Paget's disease (closed to accrual) Peritoneal mesothelioma Basal cell

lipase
measurable disease
oophorectomy
bronchoalveolar carcinoma
bone scan
  • 6621 views
  • 25 May, 2022
  • 767 locations
Treatment of Malignant Peritoneal Mesothelioma (MESOTIP)

MESOTIP is a randomized trial evaluating the association of PIPAC and systemic chemotherapy versus systemic chemotherapy alone as 1st-line treatment of Malignant Peritoneal Mesothelioma In this

pressurized intraperitoneal aerosol chemotherapy
peritoneal mesothelioma
pemetrexed
systemic chemotherapy
cytoreductive surgery
  • 128 views
  • 14 Nov, 2021
  • 1 location
Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma

For cancers, such as mesothelioma, that spread to the lining of the stomach, detecting the cancer is very difficult with CT or MRI scans. Researchers at the University of Chicago want to find out if the new experimental MRI and ultrasound imaging techniques do a better job of detecting these …

cancer
peritoneal mesothelioma
  • 2 views
  • 25 Jan, 2021
  • 1 location
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

This phase II trial compares the usual treatment alone to using immunotherapy (atezolizumab) plus the usual treatment in treating patients with peritoneal mesothelioma. The usual treatment

  • 0 views
  • 24 May, 2022
  • 8 locations
A Study of Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma

This study is for individuals who have peritoneal mesothelioma, a cancer of the lining of your abdominal wall and organs (the peritoneum). Doctors leading the study would like to determine the

chemotherapy regimen
cancer
peritoneal mesothelioma
  • 0 views
  • 16 Mar, 2022
  • 1 location
Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies

Background Cytoreductive surgery (CRS) removes tumors in the abdomen. HIPEC is heated chemotherapy that washes the abdomen. CRS and HIPEC may help people with peritoneal carcinomatosis. These are tumors that have spread to the lining of the abdomen from other cancers. Researchers think they can improve results of CRS and …

antineoplastic
absolute neutrophil count
oxaliplatin
cytoreduction
doxorubicin
  • 0 views
  • 16 May, 2022
  • 1 location
  • 2 views
  • 26 Sep, 2021
  • 2 locations
Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis (COCOON)

The investigator proposes to use the cardiac coherence technique to diminish anxiety before the surgery of a peritoneal carcinosis of colon or stomach or ovary and pseudomyxoma or peritoneal

  • 0 views
  • 22 Mar, 2022
  • 1 location
CAR T Cells in Mesothelin Expressing Cancers

Phase I study to establish safety and feasibility of both intravenous administration and local delivery of lentiviral transduced huCART-meso cells with or without lymphodepletion.

peritoneal mesothelioma
adenocarcinoma
cns metastases
cns disease
pericardial effusion
  • 69 views
  • 03 Feb, 2022
  • 1 location
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer

Gavocabtagene autoleucel (gavo-cel; TC-210) is a novel cell therapy that consists of autologous genetically engineered T cells expressing a single-domain antibody that recognizes human Mesothelin, fused to the CD3-epsilon subunit which, upon expression, is incorporated into the endogenous T cell receptor (TCR) complex. This Phase 1/2 study aims to establish …

peritoneal mesothelioma
lung cancer
cancer
adenocarcinoma
lung carcinoma
  • 40 views
  • 03 Feb, 2022
  • 7 locations